Literature DB >> 7987656

C3 nephritic factor and SLE: report of four cases and review of the literature.

M J Walport1, K A Davies, M Botto, M A Naughton, D A Isenberg, D Biasi, R J Powell, N T Cheung, G R Struthers.   

Abstract

We present four patients with C3 nephritic factor associated with partial lipodystrophy and/or mesangiocapillary glomerulonephritis type II. Each of these patients subsequently developed features of SLE, with an onset between 2 and 24 years after the development of the lipodystrophy or glomerulonephritis. All four patients had antinuclear antibodies and three of the four had anti-Ro antibodies. These patients bring to six the number of reported cases of this association. Possible explanations for the link between these two conditions are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7987656

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  15 in total

1.  Partial lipodystrophy, polycystic ovary syndrome and proteinuria: a common link to insulin resistance?

Authors:  V C Blackwell; P Salis; R W Groves; S E Baldeweg; G S Conway; R J Unwin
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

Review 2.  The role of complement in inflammatory diseases from behind the scenes into the spotlight.

Authors:  Maciej M Markiewski; John D Lambris
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

3.  C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?

Authors:  Mariam P Alexander; Fernando C Fervenza; An S De Vriese; Richard J H Smith; Samih H Nasr; Lynn D Cornell; Loren P Herrera Hernandez; Yuzhou Zhang; Sanjeev Sethi
Journal:  J Nephrol       Date:  2015-07-18       Impact factor: 3.902

Review 4.  Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.

Authors:  Marina Noris; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Pediatr Nephrol       Date:  2018-06-09       Impact factor: 3.714

5.  Detection of C3 Nephritic Factor by Hemolytic Assay.

Authors:  Melchior Chabannes; Véronique Frémeaux-Bacchi; Sophie Chauvet
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.

Authors:  Y Levy; J George; E Yona; Y Shoenfeld
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

7.  Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis.

Authors:  Vasil V Vasilev; Remi Noe; Marie-Agnes Dragon-Durey; Sophie Chauvet; Valentin J Lazarov; Boriana P Deliyska; Veronique Fremeaux-Bacchi; Jordan D Dimitrov; Lubka T Roumenina
Journal:  J Biol Chem       Date:  2015-08-05       Impact factor: 5.157

Review 8.  Autoantibody stabilization of the classical pathway C3 convertase leading to C3 deficiency and Neisserial sepsis: C4 nephritic factor revisited.

Authors:  Elizabeth C Miller; Nicole M Chase; Peter Densen; Mary K Hintermeyer; James T Casper; John P Atkinson
Journal:  Clin Immunol       Date:  2012-09-28       Impact factor: 3.969

Review 9.  The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.

Authors:  Federica Defendi; Nicole M Thielens; Giovanna Clavarino; Jean-Yves Cesbron; Chantal Dumestre-Pérard
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

10.  Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype.

Authors:  S Berger; G Ceccarini; G Scabia; I Barone; C Pelosini; F Ferrari; S Magno; A Dattilo; L Chiovato; P Vitti; F Santini; M Maffei
Journal:  Int J Obes (Lond)       Date:  2017-07-10       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.